| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021263129-A1 | Kinase inhibitor compounds and compositions and methods of use | 2020-06-26 |
| WO-2021262684-A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION | 2020-06-22 |
| WO-2021053495-A1 | Bifunctional degraders and their methods of use | 2019-09-16 |
| TW-202123942-A | Brd9 bifunctional degraders and their methods of use | 2019-09-16 |
| WO-2021046315-A2 | Inhibitors of encephalitic alphaviruses | 2019-09-05 |
| WO-2020236688-A1 | Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetes | 2019-05-22 |
| US-2020361939-A1 | Modulators of alpha-1 antitrypsin | 2019-05-14 |
| US-2020206216-A1 | Inhibitors of fibroblast activation protein | 2018-12-21 |
| CN-113811529-A | Fibroblast activation protein inhibitor | 2018-12-21 |
| KR-20210092312-A | 3,3-difluoroallylamine or salts thereof and pharmaceutical compositions comprising the same | 2018-12-14 |
